Log in to save to my catalogue

Pharmacological characterization of linzagolix, a novel, orally active, non‐peptide antagonist of go...

Pharmacological characterization of linzagolix, a novel, orally active, non‐peptide antagonist of go...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2675602440

Pharmacological characterization of linzagolix, a novel, orally active, non‐peptide antagonist of gonadotropin‐releasing hormone receptors

About this item

Full title

Pharmacological characterization of linzagolix, a novel, orally active, non‐peptide antagonist of gonadotropin‐releasing hormone receptors

Publisher

Australia: Wiley Subscription Services, Inc

Journal title

Clinical and experimental pharmacology & physiology, 2022-10, Vol.49 (10), p.1082-1093

Language

English

Formats

Publication information

Publisher

Australia: Wiley Subscription Services, Inc

More information

Scope and Contents

Contents

Control of gonadotropin‐releasing hormone (GnRH) signalling is an effective strategy for the treatment of sex hormone‐dependent diseases. GnRH analogues have been widely used for treating these diseases; however, initial stimulation or complete suppression of GnRH signalling by GnRH analogues results in the occurrence of several distinct adverse ef...

Alternative Titles

Full title

Pharmacological characterization of linzagolix, a novel, orally active, non‐peptide antagonist of gonadotropin‐releasing hormone receptors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2675602440

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2675602440

Other Identifiers

ISSN

0305-1870

E-ISSN

1440-1681

DOI

10.1111/1440-1681.13688

How to access this item